Developing Antibody Defenses
https://www.embs.org/pulse/wp-content/uploads/sites/13/2020/10/Mertz-AntibodyDefense-iStock-625770028.jpg
2000
1500
IEEE Pulse
//www.embs.org/pulse/wp-content/uploads/sites/13/2022/06/ieee-pulse-logo2x.png
Long before the coronavirus-2019 (COVID-19)
pandemic began, four research groups—two at universities
and two at biotechnology companies—were
preparing for it by tackling a seemingly outlandish challenge
proffered by the Defense Advanced Research
Projects Agency (DARPA) of the U.S. Department of
Defense: find a stopgap defense against emerging
pathogens, so people would have protection until
a longer-term solution, notably a vaccine, became
available.
read more